Llwytho...
Long‐acting beta2‐agonists as an inhaled corticosteroid‐sparing agent for chronic asthma in adults and children
BACKGROUND: The addition of a long acting beta agonist (LABA) to inhaled corticosteroid (ICS) therapy can improve asthma symptoms and reduce exacerbations. The addition of LABA may also have an ICS‐sparing effect and permit a reduction in ICS maintenance dose. OBJECTIVES: To determine the efficacy o...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cochrane Database Syst Rev |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley & Sons, Ltd
2005
|
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7387286/ https://ncbi.nlm.nih.gov/pubmed/16235393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005076.pub2 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|